The FDA is issuing a new warning about a rare but "severe" risk associated with the long-term use of certain over-the-counter allergy medica...

Phase 1/2 first-in-human clinical study planned this year SHANGHAI and SAN DIEGO, May 22, 2025 /PRNewswire/ -- Duality Biotherapeutics ("Dua...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall, but FDA offic...

(NEXSTAR) – Hundreds of people who stopped using allergy medications like Zyrtec and Xyzal noticed an uncomfortable new side effect, the U.S...

By CARLA K. JOHNSONExcess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like W...

Approximately a year after the FDA rejected its previous approval submission, Abeona announced that the agency had approved ZEVASKYN, its au...

The 0.3% foam formulation of roflumilast was previously approved for the treatment of seborrheic dermatitis in adults and children aged 9 ye...

CDC and FDA officials are investigating the outbreak after 9 patients were hospitalized amid cucumber recall.

By MICHAEL R. BLOODLOS ANGELES (AP) — Many of Kamala Harris’ supporters and detractors alike think she’d have better odds running for Calif...

By MARY CLARE JALONICKWASHINGTON (AP) — The Senate voted on Thursday to block California’s first-in-the nation rule banning the sale of new...

By COLLIN BINKLEY, AP Education WriterWASHINGTON (AP) — A federal judge on Thursday blocked President Donald Trump’s executive order to shu...

The FDA is likely to approve the first treatment for smoldering multiple myeloma but pass on a new option relapsed/refractory DLBCL, after v...

WASHINGTON (AP) — Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and...

A band of clinicians and chronic pain advocates are pushing regulators to scrutinize a controversial risk rating tool. Medscape Medical N...

The agency will require manufacturers to add a warning to prescription and OTC labeling about the risk of itching and the potential to resol...